Response by Solomon to Letter Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study"
Circulation
.
2019 Jul 9;140(2):e92-e93.
doi: 10.1161/CIRCULATIONAHA.119.040941.
Epub 2019 Jul 8.
Author
Scott D Solomon
1
Affiliation
1
Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA.
PMID:
31283371
DOI:
10.1161/CIRCULATIONAHA.119.040941
No abstract available
Publication types
Letter
Comment
MeSH terms
Amyloid Neuropathies, Familial / genetics*
Humans
Prealbumin / genetics*
RNA Interference
RNA, Small Interfering
Substances
Prealbumin
RNA, Small Interfering
patisiran